• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Hinge Health Study: Exercise Therapy with Wearable Sensors Improves Chronic Knee Pain by 61%

by Fred Pennic 05/23/2018 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Hinge Health Knee Sensors Man

Hinge Health, a Silicon Valley-based digital health company, today announced the results about the first clinical study, published April 2018 in the Journal of Medical Internet Research demonstrates that a mobile-first, at-home exercise therapy and behavioral coaching solution improves outcomes for chronic knee pain by 61% and elective surgeries by 63% without opioids or surgery (N=162). A cost-benefit analysis estimates that the study’s employer saved $438,000 in avoided surgeries across the 101 participants in the Hinge Health treatment group. Participants who completed the program averaged 3.3 exercise therapy sessions per week and engagement each week averaged 80%.

The Hinge Health program has the potential to break the cycle of opioid use by getting in front of drugs and surgery with a program that makes best-practice knee pain care accessible at home in 10 minute activities. he customized program includes unlimited access to 1-on-1 behavioral coaching, exercise therapy with wearable motion-sensors, and interactive education. Chronic knee pain impacts 1 out of 4 adults over the age of 55 and is the second highest category of musculoskeletal spend after back pain.’

 

 Because of this program, I was able to throw the football and spend time with my son. He’s been away at college and I haven’t seen him since starting the exercises. He was shocked that I was able to run and jump and throw the ball around the backyard with no pain at all,” said a 49-year-old Transportation Manager from Virginia on the Hinge Health program. 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Biosensors, exercise therapy, Hinge Health, Medical Sensors, physical therapy

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |